This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Timing tax-loss harvesting with index funds can maximize tax efficiency in retirement accounts while maintaining asset allocation and growth potential.
17,783 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Bitwise’s Matt Hougan argues that Strategy’s role as Bitcoin’s dominant corporate buyer is shifting as institutions s...
Global regulators are tightening the rules around AI financing as investment soars, signaling potential shifts in fun...
Billionaire John Arnold Already backs a major push to study sports betting risks, awarding $2.6 million to 12 univers...
A private moment at a public arena can reveal more than gossip. This article uses the leaked taylor swift travis mome...
XRP fell near $1.08 as big-money moves on the XRP Ledger quieted and ETF flows turned negative, underscoring a cautio...
Tech markets are split: cybersecurity chip stocks soaring as AI chips gain traction, even as software stocks wobble. ...
Markets opened with heavy volatility after reports that iran just crossed trump’s red line, signaling a potential wid...
A veteran on-chain analyst says bitcoin entering phase bear as volatility climbs and liquidity tightens, signaling a ...
Starting with $1,000 doesn’t limit your ability to build lasting passive income. This guide presents two dependable d...
A major investment manager recently disclosed a sizable position in Varonis Systems. This article unpacks what the mo...
Authorities say 72 tigers died thai zoos in Chiang Mai from canine distemper, not bird flu, easing human health fears...